Anticipated $-0.01 EPS for ICC Labs Inc. (ICC) on May, 29

May 16, 2018 - By Robert Shackelford

On May, 29 WallStreet anticipated ICC Labs Inc. (CVE:ICC)’s earnings report, as reported by RTT. EPS of $-0.01 is 0.00 % from 2017’s $-0.01 EPS. ICC is touching $1.34 during the last trading session, after decreased 2.19%.ICC Labs Inc. has volume of 76,382 shares. Since May 17, 2017 ICC has 0.00% and is . ICC underperformed the S&P 500 by 11.55%.

ICC Labs Inc. produces and sells cannabis in Uruguay.The company has $184.98 million market cap. It offers recreational cannabis, cannabinoid extracts, and by-products for medicinal use, as well as industrial hemp.Currently it has negative earnings. The firm was formerly known as ICC International Cannabis Corporation and changed its name to ICC Labs Inc. in December 2017.

There’s an important ICC Labs Inc. (CVE:ICC) news released by Midasletter.com. It’s a report titled: “Canada Cannabis Roundup: ICC Labs, Choom, Delta 9 Cannabis, Hiku, WeedMD, Indiva, Golden Leaf Holdings” on April 19, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.